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results uncover a mechanism for adapta-
tion to hypoxia and support a model
whereby increased mitochondrial ROS
prevent age-related pathologies.
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Metazoans adapt to a low-oxygen environment (hyp-
oxia) throughactivationof stress-responsepathways.
Here, we report that transient hypoxia exposure
extends lifespan in C. elegans through mitochondrial
reactive oxygen species (ROS)-dependent regula-
tion of the nutrient-sensing kinase target of rapa-
mycin (TOR) and its upstream activator, RHEB-1.
The increase in lifespan during hypoxia requires
the intestinal GATA-type transcription factor ELT-2
downstreamofTORsignaling.UsingRNAsequencing
(RNA-seq), we describe an ELT-2-dependent hypoxia
response that includes an intestinal glutathione
S-transferase, GSTO-1, and uncover that GSTO-1
is required for lifespan under hypoxia. These re-
sults indicate mitochondrial ROS-dependent TOR
signaling integrates metabolic adaptations in order
to confer survival under hypoxia.INTRODUCTION
Oxygen serves as the final electron acceptor during mitochon-
drial oxidative phosphorylation and, thus, plays a crucial role in
cellular metabolism and energy production. During periods of
low oxygen (i.e., hypoxia), the cell activates adaptive responses
that concomitantly increaseoxygendelivery anddampenoxygen
demand by tissues (Semenza, 2011). The best-characterized
response to hypoxia is the activation of a family of transcription
factors known as hypoxia-inducible factors (HIFs) (Majmundar
et al., 2010). HIFs are heterodimers consisting of two basic-helix-
loop-helix/PAS proteins, HIF-1a and HIF-1b. While the HIF-1b
subunit is constitutively expressed in the cell, the HIF-1a subunit
is only present during hypoxia. Under normoxia, HIF-1a is hy-
droxylated at proline residues by the prolyl hydroxylase, PHD2,
and subsequently targeted for degradation by an E3 ubiquitin
ligase that contains a specificity factor, the von Hippel Lindau
tumor suppressor (pVHL) (Kaelin andRatcliffe, 2008). The activity
of PHD2 is inhibited under hypoxic conditions, allowing the accu-
mulation of HIF-1a protein and subsequent binding to HIF-1b for
translocation into the nucleus. The resulting HIF transcriptional
response includes genes that promote angiogenesis and eryth-
ropoiesis and repress mitochondrial metabolism. Interestingly,HIF-1 has been shown to increase the replicative capacity of
mammalian cells, suggesting that activation of HIF targets may
be a strategy to prevent age-related declines in cellular function
(Bell et al., 2007; Welford et al., 2006).
A common genetic model to study organismal aging is the
nematode C. elegans, which has a conserved HIF-1-dependent
hypoxia response regulated by VHL and the PHD2 homolog,
EGL-9. HIF-1 is necessary and sufficient to extend the lifespan
of C. elegans (Mehta et al., 2009; Zhang et al., 2009), but, aside
from HIF activation, there is very little known about hypoxia-initi-
ated pathways that promote metabolic adaptation to increase
lifespan. To address this question, we developed a transient
hypoxia assay in which C. elegans were exposed to a single
36 hr treatment of hypoxia. We uncovered that transient hypoxia
exposure was sufficient to extend lifespan in C. elegans through
mitochondrial reactive oxygen species (ROS)-dependent regula-
tion of the nutrient-sensing kinase TOR (target of rapamycin)
and its upstream activator, RHEB-1. Interestingly, inactivation
of RHEB-1 in intestinal cells was sufficient to block longevity
under transient hypoxia suggesting that the hypoxia response
was not cell-autonomous. This led to the identification of the in-
testinal GATA-type transcription factor, ELT-2 as a key mediator
of the transient hypoxia response, independent from HIF-1.
Under transient hypoxia, ELT-2 controls the upregulation of an
intestinal glutathione S-transferase, GSTO-1, to extend lifespan.
Thus, hypoxia induces intestinal TOR and ELT-2 signaling to
extend lifespan in C. elegans.RESULTS AND DISCUSSION
Transient Hypoxia Extends Lifespan through TOR
Signaling
To investigate how the lifespan of C. elegans is affected under
transient hypoxia, animals were subjected to a single treatment
of 0.5% O2 for 36 hr either during larval development or
in adulthood (Figure 1A). Transient hypoxia was sufficient to
extend lifespan in both developing and adult worms by
18.76% and 16.19%, respectively (Figure 1B). Interestingly, the
lifespan benefit from transient hypoxia treatment was compara-
ble to C. elegansmaintained continuously under hypoxia (Leiser
et al., 2013), suggesting hypoxia might induce a metabolic
switch to increase lifespan. To investigate this possibility,
we screened three nutrient-sensing pathways: FOXO, AMPK,
and TOR, which have been previously implicated in regulating
lifespan in C. elegans (Kenyon, 2010).Cell Reports 9, 9–15, October 9, 2014 ª2014 The Authors 9
Figure 1. TOR Is Required for Longevity following Transient Hypoxia
(A) Methods for transient hypoxia treatment in C. elegans fed OP50 bacteria.
(B) Transient hypoxia during either development or adulthood is sufficient to
extend lifespan.
(C) Methods for transient hypoxia treatment in C. elegans fed HT115 dsRNA
producing bacteria. On day 3 of adulthood, animals may be removed to vector
control plates (transient RNAi) or maintained on dsRNA producing bacteria
(continuous RNAi).
(D) Transient RNAi of theC. elegans TOR homolog, LET-363, prevents lifespan
extension following transient hypoxia treatment. Cox proportional hazard
analysis of transient control RNAi and transient TOR RNAi under hypoxia =
1.618 (95% CI 1.311–1.997).The C. elegans FOXO homolog, DAF-16, is negatively regu-
lated by the insulin-like growth factor (IGF) receptor, DAF-2,
and mutations impairing IGF signaling extend lifespan (Kenyon
et al., 1993). However, animals bearing a null mutation in
DAF-16, daf-16(mu86), were long-lived following transient hyp-
oxia treatment (Figure S1A). AMP-activated protein kinase
(AMPK) activity is promoted by increased AMP levels and thus
acts as a sensor for bioenergetic stress (Hardie et al., 2012).
We found animals bearing a null mutation in the catalytic subunit
of AMPK, aak-2(gt33), were also long-lived when treated with
transient hypoxia (Figure S1B). Lastly, TOR is a serine-threonine
kinase that responds to nutrient availability to concomitantly
stimulate anabolic and suppress catabolic metabolic pathways.
To test whether TOR signaling was required for longevity
following transient hypoxia, we adapted our hypoxia protocol
for RNAi feeding and included methods for both transient
and continuous TOR RNAi (Figure 1C). Transient RNAi of the
C. elegans TOR homolog LET-363 significantly reduced lifespan
following hypoxia treatment (Figure 1D). Furthermore, while10 Cell Reports 9, 9–15, October 9, 2014 ª2014 The Authorscontinuous TOR RNAi in adulthood blocked longevity follow-
ing transient hypoxia exposure, it also extended lifespan of
wild-type C. elegans, as previously reported (Figures S1C and
S1D). Collectively, these results indicate that hypoxia extends
lifespan in a TOR-dependent but AMPK- and FOXO-indepen-
dent manner.
TORC1 Is Required for Lifespan following Transient
Hypoxia
TOR is a component of two large protein complexes known as
TOR complex I (TORC1) and TOR complex 2 (TORC2) (Laplante
and Sabatini, 2012). TORC1 and TORC2 share common sub-
units but also have distinct proteins within their complexes.
The Ras-related small G protein RHEB-1 is an upstream acti-
vator of TORC1 signaling and thus served as an attractive candi-
date to test whether TORC1 activity is required under transient
hypoxia. Indeed, transient or continuous RHEB-1 RNAi reversed
lifespan extension following transient adult hypoxia (Figures 2A
and S2A). The TOR binding protein, RAPTOR, is a 150 kDa scaf-
fold protein of the TORC1 complex and is encoded by the DAF-
15 homolog in C. elegans. Transient RNAi of RAPTORyDAF-15
also blocked longevity under transient hypoxia (Figure 2B). Addi-
tionally, RHEB-1 RNAi had no impact on the activation of HIF-
dependent transcription (F22B5.4 mRNA) under hypoxia, even
though HIF-1 was required for lifespan extension following
transient hypoxia (Figures S2B and S2C). We conclude TORC1
mediates a unique HIF-1-independent response to transient
hypoxia to extend lifespan in C. elegans.
Our results showing TORC1 promotes lifespan are surpris-
ing given that genetic or pharmacological inhibition of TORC1
signaling extends lifespan in multiple organisms, including
C. elegans (Hansen et al., 2007; Kaeberlein et al., 2005; Kapahi
et al., 2004; Wu et al., 2013). While TOR RNAi reproduces this
phenotype (Figures S1C and S1D), our transient hypoxia data
suggest the requirement of TOR signaling in promoting or sup-
pressing lifespan is likely dependent on various nutritional con-
ditions. Supporting this, TORC1 activity is required to promote
longevity in response to intermittent fasting (Honjoh et al.,
2009).
Canonical TORC1 signaling promotes cellular growth by
increasing protein synthesis through phosphorylation of P70/
S6-kinase and inhibiting catabolic processes such as autophagy
(Laplante and Sabatini, 2012). AC. elegans strain featuring amu-
tation in the S6-kinase homolog, RSKS-1, displayed increased
lifespan under transient hypoxia, despite being long-lived under
normoxic conditions, suggesting transient hypoxia does not
extend lifespan by reducing protein synthesis (Figure S2D). Addi-
tionally, we utilized a C. elegans fluorescent reporter strain that
allows quantification of autophagic vesicles within the intestine
of the animal (LGG-1::RFP), a process activated following
TORC1 inhibition (Robida-Stubbs et al., 2012). Indeed, RHEB-
1 RNAi increased puncta formation (Figure 2C). However,
transient hypoxia treatment did not increase the number of quan-
tifiable puncta, indicating TORC1 signaling is still active under
hypoxia. These data support a model in which TORC1 signaling
promotes longevity under transient hypoxia.
In mammalian cells, hypoxia is known to negatively regulate
TORC1 signaling (Arsham et al., 2003; Wouters and Koritzinsky,
Figure 2. TORC1 and ROS Are Necessary
for Transient Hypoxia Extension of Lifespan
(A) Transient RNAi of the TORC1 activator, RHEB-
1, prevents longevity following transient hypoxia
treatment.
(B) Transient RNAi of the TORC1 scaffold protein
RAPTOR prevents adaptation to hypoxia.
(C) Transient hypoxia does not increase autophagy
in the C. elegans nhx-2::LGG-1::RFP reporter
strain, suggesting TORC1 is not inhibited under
hypoxia (*p < 0.05; NS, not significant).
(D) Methods for BHA treatment in C. elegans.
(E) The antioxidant BHA suppresses longevity
following transient hypoxia compared to ethanol
(ETOH) control.2008). Nonetheless, it is important to note that multiple cell types
proliferate in vitro under hypoxic conditions, including human
hematopoietic stem cells and human fibroblasts (Bell et al.,
2007; Danet et al., 2003). Hypoxia also increases pulmonary
vascular smooth muscle cell proliferation through TOR signaling
(Krymskaya et al., 2011). Moreover, hypoxia is prominent in
many progrowth states, such as the developing embryo or
rapidly proliferating tumors. Thus, hypoxic regulation of TORC1
signaling is likely context dependent.
Mitochondrial ROS Released under Transient Hypoxia
Extend Lifespan through TORC1
A key question to decipher is how cells sense decreases in oxy-
gen levels and couple it to TOR signaling to impart metabolic ad-
aptations and increased lifespan. We have previously proposed
that mitochondria are critical for oxygen sensing by releasing
ROS during hypoxia to activate multiple signaling pathways,
including HIFs (Hamanaka and Chandel, 2009). Along these
lines, long-lived mitochondrial mutants in C. elegans featureCell Reports 9, 9–elevated ROS levels that activate HIF-
1-dependent longevity pathways (Lee
et al., 2010). Furthermore, numerous
studies in yeast, C. elegans, and mice
indicate that increasing ROS promote
longevity (Liu et al., 2005; Pan et al.,
2011; Schulz et al., 2007; VanRaamsdonk
and Hekimi, 2009; Zarse et al., 2012). Ox-
idants in mammalian cells have also been
shown to activate TOR signaling (Sarbas-
sov and Sabatini, 2005). Therefore, we
surmised that ROS might couple oxygen
sensing to TOR signaling. To test whether
ROS were required for lifespan under
transient hypoxia, we treated C. elegans
with the antioxidant butylated hydrox-
yanisole (BHA) for the 3 days adjacent
to hypoxia exposure (Figure 2D). As ex-
pected, hypoxia increased mean lifespan
from 19.7 days compared to 24.3 days in
C. elegans treated with ethanol control
(Figure 2E). By contrast, hypoxia only
slightly increased mean lifespan from20.8 days to 21.6 days in animals treated with BHA (Figure 2E).
Thus, increased ROS under hypoxia serve as biological signaling
molecules to activate adaptive responses to increase lifespan in
C. elegans.
Intestinal TORActivity Is Required for Lifespan following
Transient Hypoxia
Recent studies indicate stress responses in C. elegans can
be regulated in a cell-non-autonomous manner whereby the
C. elegans intestine integrates an organismal response to envi-
ronmental change (Durieux et al., 2011). To investigate whether
this was case for the TORC1-dependent hypoxia response,
we inactivated TORC1 using tissue-specific RNAi strains. The
C. elegans rde-1(ne219) strain cannot process double-stranded
RNA (dsRNA) due to a mutation in RDE-1, an Argonaute family
protein, and is RNAi deficient (Tabara et al., 1999). Transgenic
C. elegans strains reconstituted with RDE-1 driven under
various promoters permit RNAi knockdown in a tissue-specific
manner (Qadota et al., 2007). Intestinal RNAi of RHEB-1, using15, October 9, 2014 ª2014 The Authors 11
Figure 3. Intestinal TORC1 and ELT-2
Signaling Is Required for Lifespan under
Hypoxia
(A) The rde-1(ne219);nhx-2::rde-1 mutant features
intact RNAi machinery only in the C. elegans in-
testine. Impairment of intestinal TORC1 signaling
prevents longevity following transient hypoxia.
(B) Methods for ELT-2 RNAi feeding during adult-
hood in C. elegans.
(C) ELT-2 is a GATA-type transcription factor
required for development and maintenance of the
nematode intestine. ELT-2 RNAi in the adult animal
prevents longevity following adult transient hyp-
oxia. Cox proportional hazard analysis of control
RNAi and ELT-2 RNAi under hypoxia = 3.907 (95%
CI 2.802–5.447).
(D) ELT-2 RNAi following larval transient hypoxia
also prevents hypoxia-induced lifespan.
(E) The HIF-1-dependent gene F22B5.4 is induced
following transient hypoxia. ELT-2 RNAi does not
affect F22B5.4 upregulation under hypoxia, sug-
gesting that ELT-2 controls a HIF-1-independent
hypoxia response (**p < 0.01; NS, not significant).the nhx-2 promoter to drive RDE-1 expression, prevented
increased lifespan following transient hypoxia (Figure 3A).
Thus, RHEB-1 signaling in the C. elegans intestine is required
to extend lifespan under transient hypoxia.
The nematode intestine, the primary organ responsible for
digestion of ingested bacteria and absorption of nutrients, also
plays a central role in the storage of lipids and fat metabolism
as well as in the synthesis of lipid-derived hormones
and signaling molecules. The mitochondrial unfolded protein
response (UPRmt) specifically activated in the intestine
triggers a cell-non-autonomous signaling response to extend
C. elegans lifespan (Durieux et al., 2011). Thus, we sought to
determine whether longevity following transient hypoxia required
intestinal UPRmt activation. To do this, we induced the UPRmt
through RNAi of ISP-1, a critical protein required for proper as-
sembly of electron transport chain complex III. ISP-1 RNAi was
sufficient to extend lifespan compared to wild-type controls,
but cotreatment of ISP-1 RNAi with transient hypoxia led
to a further 28.12% lifespan increase (Figure S3B). HAF-1 and
ATFS-1 are two key mediators of the UPRmt implicated in modu-
lating lifespan (Figure S3A) (Houtkooper et al., 2013; Pellegrino
et al., 2013). Transient hypoxia extended the lifespan of
C. elegans containing a deletion in the HAF-1 (Figure S3C)
and in C. elegans fed RNAi to reduce ATFS-1 expression (Fig-
ure S3D). Alternatively, ATFS-1 was required for lifespan
extension by ISP-1 RNAi (Figure S3D). These data indicate that
activation of UPRmt does not contribute to lifespan extension
under transient hypoxia.12 Cell Reports 9, 9–15, October 9, 2014 ª2014 The AuthorsELT-2 Increases Intestinal GSTO-1
Expression to Extend Lifespan
under Hypoxia
The requirement for RHEB-1 in the intes-
tine during hypoxia led us to examine
whether the intestinal-specific GATA-
type erythroid-like-2 transcription factor(ELT-2) is required for increased lifespan following transient hyp-
oxia (McGhee, 2007). ELT-2 plays a critical role in the differenti-
ation of the intestine in the developing embryo and regulates the
expression of intestinal genes in the adult (McGhee et al., 2007).
To avoid the developmental effects of larval ELT-2 RNAi, we fed
C. elegans ELT-2 RNAi bacteria beginning at the L4/young adult
stage, 60 hr after synchronized egg lay (Figure 3B). RNAi of ELT-
2 blocked longevity following transient hypoxia regardless of
whether the animals were exposed to hypoxia in adulthood or
development (Figures 3C and 3D). To eliminate the possibility
that ELT-2 RNAi interferes with the canonical HIF-1 hypoxia
response in C. elegans, we measured induction of the HIF-1
target F22B5.4 in animals fed ELT-2 RNAi under hypoxia. Impor-
tantly, no difference in F22B5.4 induction was observed upon
ELT-2 RNAi, suggesting ELT-2 mediates unique adaptions to
hypoxia within the intestine (Figure 3E).
To understand the genes and cellular pathways controlled by
ELT-2, we performed an RNA-sequencing analysis on adult
animals treated with transient hypoxia and ELT-2 RNAi. Twelve
transcripts were upregulated under hypoxia in an ELT-2-depen-
dent manner, and we noted multiple candidates with known
functions in fatty acid metabolism and ROS homeostasis (Table
S1). The expression changes of these candidates were
confirmed and quantified by RT-PCR (Figure 4A). Of particular in-
terest was the identification of GSTO-1, an intestinal omega-
class glutathione S-transferase (GST), whose induction under
hypoxia was abrogated by ELT-2 RNAi. GSTs are a broad class
of intracellular proteins with ROS-scavenging activity in addition
Figure 4. GSTO-1 Is Required for Lifespan
following Transient Hypoxia
(A) C. elegans treated with transient adult hypoxia
and fed ELT-2 RNAi bacteria were harvested for
total RNA and analyzed by RNA-Sequencing for
ELT-2-dependent transcriptional changes. In the
adult animal, 75 transcripts were upregulated un-
der hypoxia, 12 of which were determined to be
ELT-2-dependent (see Table S1). Select candi-
dates involved in lipid metabolism (acs-2, fat-4,
fat-6, and T10B5.7), ROS homeostasis (gsto-1 and
fmo-2), and neurotransmission (comt-4) were
verified by RT-PCR.
(B) Hypoxia induction of the omega-class gluta-
thione S-transferase, GSTO-1, requires intestinal
TORC1 activity. However, intestinal TORC1 activ-
ity is not required for upregulation of the HIF-1-
dependent target, F22B5.4 (*p < 0.05; NS, not
significant).
(C) GSTO-1 RNAi in wild-type animals (N2) pre-
vents lifespan following transient hypoxia.
(D) Intestinal-specific GSTO-1 RNAi in the nhx-
2::rde-1 transgenic strain is sufficient to prevent
hypoxia-induced longevity.to their role in the metabolism of xenobiotics (Burmeister et al.,
2008). Along these lines, loss of GSTO-1 increases the sensitivity
of C. elegans to mitochondrial ROS-generating agents,
such as paraquat (PQ). To determine if hypoxic induction of
GSTO-1 was dependent on intestinal TORC1, we measured
gsto-1 mRNA levels under hypoxia following feeding of TOR
and RHEB-1 RNAi. Indeed, TORC1 RNAi specifically in the
C. elegans intestine impaired upregulation of gsto-1while having
no effect on HIF-1-dependent targets (Figure 4B). GSTO-1 RNAi
also completely suppressed longevity following transient hypox-
ia when performed in wild-type animals (Figure 4C) and intestinal
RNAi-sufficient strains (Figure 4D).
Previous studies have shown that transient and low-dose
levels of mitochondrial ROS, achieved through exposure to
PQ, are sufficient to extend lifespan in C. elegans (Yee et al.,
2014). We therefore hypothesized that the mechanism of
longevity following PQ treatment involves induction of antioxi-
dants, such as GSTO-1, through TORC1/ELT-2 signaling. To
test this, C. elegans were treated for 72 hr with 0.25 mM PQ
and subsequently scored for mean lifespan (Figure S4A).
While PQ exposure was sufficient to increase lifespan (Fig-
ure S4B), RNAi of the TORC1 components RHEB-1 and TOR
or the intestinal transcription factor ELT-2 completely pre-
vented the mitohormesis phenotype (Figures S4C–S4E).
Importantly, GSTO-1 is also required for longevity following
PQ treatment, an observation consistent with previous studies
(Figure S4F).Cell Reports 9, 9–These data support a model where
a HIF-independent but TOR-dependent
signaling pathway extends lifespan in
C. elegans following transient hypoxia
exposure. The TOR-dependent hypoxia
response is initiated by mitochondrial
ROS within the intestine to induce anELT-2 transcriptional network. ELT-2 and TOR directly upregu-
late expression of the glutathione S-transferaseGSTO-1, leading
to increased lifespan. Our results are consistent with multiple
studies that have been reported whereby increasing mitochon-
drial ROS provides a lifespan benefit through activation of adap-
tive stress-response pathways (i.e., mitohormesis) (Ristow and
Schmeisser, 2011). It is worth noting that human randomized
control trials for administration of antioxidants continue to mea-
sure no mortality- or disease-prevention benefits (Bjelakovic
et al., 2007). Perhaps the reverse strategy of administering tran-
sient and low doses of ROS-generating agents within specific
mammalian tissues might activate stress pathways that improve
age-related pathologies.
EXPERIMENTAL PROCEDURES
C. elegans Strains and Maintenance
All strains used in this study were obtained from the C. elegansGenetic Center
at the University of Minnesota. Animals were maintained and passaged at
20C on NGM media seeded with an OP50 bacteria lawn.
RNAi Methods
Primers used to generate RNAi constructs are depicted in the Supplemental
Experimental Procedures. To generate RNAi clones, amplified fragments
from C. elegans N2 wild-type cDNA were ligated into the L4440 vector using
XhoI and PstI restriction sites and the manufacturer’s T4 ligase protocol
(New England Biolabs). Candidates were verified by sequencing. The L4440
RNAi vector was then transformed into the HT115 feeding strain and verified
by restriction digest.15, October 9, 2014 ª2014 The Authors 13
Solid nematode growth media (NGM) RNAi media was generated by adding
1.429 g/l isopropyl b-D-1 thiogalactopyranoside (IPTG) (GoldBio), 0.075 g/l
ampicillin (Sigma-Aldrich), 12.5 mg/l tetracycline (Sigma-Aldrich), and 1 mg/l
Amphotericin B (Sigma-Aldrich) to lukewarm NGM media prior to pouring.
RNAi cultures were inoculated in Luria broth containing ampicillin
(100 mg/ul), tetracycline (12.5 mg/ul), and Amphotericin B (1 mg/ul) from frozen
glycerol stocks for 12–14 hr prior to adding IPTG (1 mM, 4 hr) to induce dsRNA
expression. Small plates (35 mm diameter) were seeded with 200 ml RNAi cul-
ture, and large plates (10 mmdiameter) were seeded with 1ml. Bacterial lawns
were dried at room temperature for up to 3 days before use.
Lifespan Analysis and Hypoxia Treatment
For all lifespan experiments, C. elegans were synchronized with a 4–6 hr
egg lay (EL). N2 animals were transferred to FUDR (Sigma-Aldrich) at 60 hr
after EL (L4/young adult stage); 84 hr after EL represents day 1 of adulthood.
rsks-1(ok1255) animals are slightly developmentally delayed and were trans-
ferred to FUDR upon reaching the L4/young adult stage. A total of 50 mM
FUDR was used to prevent progeny from hatching on OP50-seeded NGM
plates, while 5 mM FUDR was sufficient to block hatching on HT115 RNAi
plates. Animals were scored alive or dead bymanual prodding under a dissec-
tion scope.C. elegans that burst or desiccated along the sides of the Petri dish
were removed from the final analysis. Statistical analyses on lifespan curves
were performed using the Mantel-Coxylog-rank test with Prism 6 software
and are presented in the lifespan supplement (Table S1). Hazard ratios were
calculated with the Cox proportional-hazard model using SSPS software.
Graphical depictions ofmethods for transient hypoxia treatment canbe found
throughout this article. In brief, hypoxia treatments were performed for 36 hr
during larval development (24 hr after EL) or during adulthood (84 hr after EL).
Treatment was performed at room temperature by flowing a 0.5%O2/balanced
N2 tank (Airgas) through an airtight chamber. Normoxia controls were kept in
an adjacent chamber exposed to ambient air. Animals were returned to 20C
after 36 hr. TORC1 and ELT-2 RNAi feeding was either performed throughout
adulthood starting 60 hr after EL (continuous RNAi) or for 3 days (transient
RNAi). GSTO-1 RNAi was performed continuously in all experiments.
BHA Treatment
The timing of C. elegans ethanol and BHA treatment is detailed in Figure 2D.
In order to prepare solid agar plates for this experiment, BHA was dissolved
in ethanol at a 1 M concentration and added 1:1,000 to cooled autoclaved
RNAi media (1 mM final concentration). An equal volume of 100% ethanol
was used as a pharmacological control.
Paraquat Treatment
The timing of transient paraquat (PQ) treatment is detailed in Figure S4A. To
prepare solid plates for this experiment, 1 M PQ dissolved in water was added
to cooled autoclaved RNAi media to a final concentration of 0.25 mM (1:4000
dilution). The growth of HT115 bacteria is impacted in the presence of PQ and
compromises RNAi knockdown. We therefore allowed HT115 bacterial lawns
to grow in the absence of PQ and subsequently manually transferred RNAi
bacteria onto control and PQ plates using a metal spatula. Following 72 hr
of PQ treatment, animals were returned to normally seeded HT115 plates.
Autophagy Assay
The nhx-2::LGG-1::RFP strain was synchronized via 4 hr EL and grown for
24 hr on control or RHEB-1 RNAi plates. Animals were then exposed to
24 hr transient hypoxia prior to quantification of intestinal fluorescent puncta
(Zeiss Axiovert). Puncta were most reliably quantified at the L3/L4 stage prior
to gonadal development. Image analysis was performed using ImageJ64 with
a maxima threshold tolerance of 100. This closely correlated with the puncta
quantified by human observation. Total puncta per square inch was calculated
by dividing the total puncta number by the intestinal fluorescent area. A
Student’s t test was used to evaluate for statistical significance (Prism 6).
RNA Sequencing and RT-PCR
ELT-2 RNAi feeding for RNA sequencing (RNA-seq) analysis was initiated dur-
ing adulthood to avoid developmental effects (Figure 4A), whereas intestinal
TOR or RHEB-1 RNAi was performed throughout development (Figure 4B).14 Cell Reports 9, 9–15, October 9, 2014 ª2014 The AuthorsFor RNA isolation, synchronized C. elegans grown on large RNAi plates
were quickly washed from solid plates and rinsed once in M9 buffer prior to
addition of 250 ml TRIzol (Invitrogen). Lysates were preserved at 80C until
RNA isolation. RNA was isolated with two chloroform extractions (50 ml
each), followed by isopropanol precipitation (125 mL) of the aqueous phase,
and a single wash of the resulting pellet with 70% ethanol (250 mL). RNA pellets
were dried in a tissue culture hood and resuspended in RNase-free water. If
necessary, RNA pellets were dissolved by heating briefly to 60C.
RNA-seq analysis was performed by Beijing Genomics on a pool of five inde-
pendent RNA samples (4 mg RNA per experiment, 20 mg total RNA). RNA was
evaluated for integrity using an Agilent Bioanalyzer 2100, and 100 bp paired-
end cDNA sequencing libraries were prepared separately for each sample
using indexed adapters. All four samples were multiplexed onto a single lane of
an Illumina HiSeq2000. After sequencing, the reads were demultiplexed by
removing adapters and filtered by censoring the reads with poor quality. Reads
were aligned to the C. elegans reference genome (ce10 from UCSC) using
TopHat (v2.0.8b) in conjunction with the ce10 gene annotation data obtained
fromUCSC.Afteralignment, transcriptswerequantifiedandadifferential expres-
sion analysis was performed using Cufflinks (v2.1.1), which calculates gene
expression as reads per kilobase transcript per million reads (RPKM) values.
cDNA for RT-PCR experiments was synthesized using 1 mg of total RNA
template and theMoloneymurine leukemia virus reverse transcriptase accord-
ing to themanufacturer’s protocol (Life Technologies). RT-PCRwas performed
using the CFX384 real-time PCR detection system (Bio-Rad) and a SYBR
green fluorophore (Bio-Rad). Total cDNA template for all reactions was 5 ng
except for the actin loading control, for which 0.1 ng of total template was
used. All reactions were performed in triplicate wells, and fold-change calcu-
lations were performed manually (Macintosh Numbers). A Student’s t test was
used to evaluate for statistical significance (Prism 6). A list of RT-PCR primers
used is provided in the Supplemental Experimental Procedures.
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